SUMITOMO PHARMA CO. LTD./ JP3495000006 /
2024-05-02 5:03:04 PM | Chg. -0.1000 | Volume | Bid5:57:17 PM | Ask5:57:17 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.2400EUR | -4.27% | 2,277 Turnover: 5,100.4800 |
2.2600Bid Size: 2,277 | 2.3200Ask Size: 2,199 | 890.5 mill.EUR | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -187.55 JPY | -232.09% |
EPS Diluted: | - JPY | - |
Revenues per Share: | 1,396.19 JPY | -0.80% |
Book Value per Share: | 1,022.24 JPY | -33.09% |
Cash Flow per Share: | 30.00 JPY | -61.79% |
Dividend per Share: | 28.00 JPY | 0.00% |
Total | in mill. | |
Revenues: | 555,544.00 JPY | -0.80% |
Net Income: | -74,512.00 JPY | -232.08% |
Operating Cash Flow: | 11,937.00 JPY | - |
Cash and Cash Equivalents: | 143,478.00 JPY | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 0.27 | 0.58 |
P/BV ratio: | 0.36 | 0.79 |
P/CF Ratio: | 12.43 | 27.00 |
PEG: | 0.01 | - |
Earnings Yield: | -50.28% | -23.15% |
Dividend Yield: | 7.51% | 3.46% |
Market Capitalization | ||
Market Capitalization: | 890.5 mill. EUR | 2.06 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | 142,480.0320 EUR | 330,034.1760 EUR |
Shares Outstanding: | 397.9 mill. |
Profitability
Gross Profit Margin: | 67.79% |
EBIT Margin: | -13.86% |
Net Profit Margin: | -13.41% |
Return on Equity: | -18.32% |
Return on Assets: | -6.57% |
Financial Strength
Liquidity I / Cash Ratio: | 38.50% |
Liquidity II / Quick Ratio: | 64.23% |
Liquidity III / Current Ratio: | 102.46% |
Debt / Equity Ratio: | 178.98% |
Dynam. Debt / Equity Ratio: | 6,098.63% |
Efficiency
Employees: | 6,250 |
Personal Expenses / Employee: | - JPY |
Revenues / Employee: | 88,887,040.00 JPY |
Net Income / Employee: | -11,921,920.00 JPY |
Total Assets / Employee: | 181,558,720.00 JPY |
* Fiscal Year End: | 2023-03-31 |
Accounting Standard: | IFRS |
Currency: | JPY |